Clinical Pathways Search Results

The penicillin drug allergy pathway is meant to guide providers in assessing whether patients with a reported or labeled penicillin drug allergy should avoid penicillin, remove the allergy label, or refer to an allergist for skin testing or oral drug challenge.

This pathway guides the ED and inpatient care for patients of any age with Genetically confirmed, Primary (Definite) Mitochondrial Disease or Suspected Mitochondrial Disease.

This pathway guides clinicians in best practices for screening and treatment for adolescents presenting to the Emergency Department and Primary Care sites who might be at risk for sexually transmitted infections.

This pathway guides the diagnosis of Somatic Symptom and Related Disorders (SSRD) where the history/physical of a patient’s chief complaint does not align with known organic medical causes.

The end of life care pathway is a detailed plan of the essential steps in end of life care for the deceased child.

This pathway recommends a systematic approach to the health assessment of children entering foster care, including physical, emotional, and developmental health.

This clinical pathway provides a detailed behavior screening tool, supportive resources and interventions for treating a pediatric patient with challenging behaviors in the primary care setting.

This pathway should be used to guide the health screening, evaluation and management of patients presenting with concerns for the mpox virus. 

The inpatient anaphylaxis pathway takes a step-by-step approach to the evaluation and treatment of a child with a of history anaphylaxis.

The anaphylaxis pathway highlights the care necessary in treating children with anaphylaxis in an outpatient setting.